CORTECH INC
SC 13D/A, 1998-06-16
PHARMACEUTICAL PREPARATIONS
Previous: GLOBAL CASINOS INC, 8-K/A, 1998-06-16
Next: CORTECH INC, 8-K, 1998-06-16




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D/A

                   UNDER THE SECURITIES EXCHANGE ACT OF 1934

                               (Amendment No. 9)*

NAME OF ISSUER:  Cortech, Inc.

TITLE OF CLASS OF SECURITIES:   Common Stock

CUSIP NUMBER:  22051J100000

NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO
RECEIVE NOTICES AND COMMUNICATIONS:

     Natalie I. Koether, Esq., Rosenman & Colin LLP
     211 Pennbrook Road, P. O. Box 97
     Far Hills, New Jersey 07931                 (908) 766-4101

DATE OF EVENT WHICH REQUIRES FILING:    June 16, 1998


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1 (b)(3) or (4), check the following: ________

     Check the  following if a fee is being paid with the  statement:  (A fee is
not required only if the reporting person:  (1) has a previous statement on file
reporting  beneficial  ownership  of more  than  five  percent  of the  class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

     Note: Six copies of this statement, including all exhibits, should be filed
with the  Commission.  See Rule 13d-1(a) for other parties to whom copies are to
be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The  information  required on the remainder of this cover shall not be deemed to
be "filed" for the purpose of Section 18 of the Securities  Exchange Act of 1934
("Act") or otherwise  subject to the  liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).

                         (Continued on following pages)


<PAGE>



CUSIP NO.:   300902103000


1.       NAME OF REPORTING PERSON:   Asset Value Fund Limited Partnership

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
         (a)      (b) XX

3.       [SEC USE ONLY]

4.       SOURCE OF FUNDS:  WC

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) OR 2(e):   YES          NO   XX

6.       CITIZENSHIP OR PLACE OF ORGANIZATION:   New Jersey

7.       SOLE VOTING POWER:   2,000,000

8.       SHARED VOTING POWER:

9.       SOLE DISPOSITIVE POWER:  2,000,000

10.      SHARED DISPOSITIVE POWER:

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
         PERSON:   2,000,000

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES:   YES        NO  XX

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):   10.80%

14.      TYPE OF REPORTING PERSON:   PN



<PAGE>

CUSIP NO.:   300902103000


1.       NAME OF REPORTING PERSON:   Mark W. Jaindl

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
         (a)     (b) XX

3.       [SEC USE ONLY]

4.       SOURCE OF FUNDS:  PF

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) OR 2(e):   YES          NO   XX

6.       CITIZENSHIP OR PLACE OF ORGANIZATION:   U.S.A.

7.       SOLE VOTING POWER:   250,000

8.       SHARED VOTING POWER:

9.       SOLE DISPOSITIVE POWER:  250,000

10.      SHARED DISPOSITIVE POWER:

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
         PERSON:   250,000

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES:   YES        NO   XX

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):   1.35%

14.      TYPE OF REPORTING PERSON:   IN

<PAGE>

CUSIP NO.:   300902103000


1.       NAME OF REPORTING PERSON:   Frederick J. Jaindl

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
         (a)     (b)  XX   

3.       [SEC USE ONLY]

4.       SOURCE OF FUNDS:  PF

5.       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) OR 2(e):   YES          NO   XX

6.       CITIZENSHIP OR PLACE OF ORGANIZATION:   U.S.A.

7.       SOLE VOTING POWER:   520,000

8.       SHARED VOTING POWER:

9.       SOLE DISPOSITIVE POWER:  520,000

10.      SHARED DISPOSITIVE POWER:

11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
         PERSON:   520,000

12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES:   YES       NO XX  

13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):   2.80%

14.      TYPE OF REPORTING PERSON:   IN

<PAGE>


Item 1.  SECURITY AND ISSUER

     This  Amendment No. 9 relates to the Schedule 13D filed on October 15, 1997
in connection with the ownership by Asset Value Fund Limited Partnership ("Asset
Value")  of shares of common  stock,  par value  $.002 per share  ("Shares")  of
Cortech,  Inc.,  a  Delaware  corporation  (the  "Company"  or  "Cortech").  The
capitalized terms used in this Amendment,  unless otherwise defined,  shall have
the same meaning as in the original Schedule 13D.


Item 4.  PURPOSE OF TRANSACTION.

     On June 16, 1998 the letter attached hereto as Exhibit G was faxed and sent
via overnight mail.


Item 7.  MATERIAL TO BE FILED AS EXHIBITS.

     Exhibit G - Letter to Edward S. Finkelstein, dated June 16, 1998


<PAGE>

                                   SIGNATURE
                                   ---------


     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.


Dated: June 16, 1998


                                        ASSET VALUE FUND LIMITED PARTNERSHIP

                                        By: Asset Value Management, Inc.
                                        General Partner


                                        By: /s/ John W. Galuchie, Jr.
                                        --------------------------------
                                        John W. Galuchie, Jr.
                                        Treasurer and Secretary



                                        /s/ Mark W. Jaindl
                                        --------------------------------
                                        Mark W. Jaindl

                                        

                                        /s/ Frederick J. Jaindl
                                        --------------------------------
                                        Frederick J. Jaindl


<PAGE>

                                    EXHIBIT F

               Letter to Edward S. Finkelstein dated June 16, 1998

                      ASSET VALUE FUND LIMITED PARTNERSHIP
                                 376 Main Street
                                  P. O. Box 74
                          Bedminster, New Jersey 07921
                                 (908) 234-1881
                               (908) 234 9355 Fax

                                            June 16, 1998

via Fax and Federal Express

Mr. Edward S. Finkelstein
17842 Argyll Terrace
Boca Raton, Florida 33496-1415

Dear Ed:

     I have had time to consider the substance of our telephone  conversation of
yesterday.  As you said we have much in common,  most particularly the desire to
have the market value of Cortech stock go up.

     As you may know, we support 1) eliminating the poison pill; 2) electing all
directors  annually;  and 3)  permitting  stockholders  who  own  10% or more of
Cortech stock to call special  meetings.  We do not know where your group stands
on these matters but opposition would not necessarily impede cooperation between
us  so  long  as  your  group  is  willing  to  submit  these  propositions  for
consideration by all stockholders at the Annual Meeting.  Assuming we can get by
these matters,  the remaining  disagreement between us is the composition of the
slate of Directors.

     Your  recommendation,  as we understood  it, was that you and we agree to a
fusion  slate  consisting  of two  "Finkelstein"  nominees  and two Asset  Value
nominees,  making a Board of four equal  peers.  However,  we believe that there
must be some  mechanics  for  breaking  a tie,  otherwise,  as we  wrote to Bert
Fingerhut,  "conflicting  opinions  among Board  members could leave the Company
directionless at a crucial crossroad in its history".  We believe that the Board
should  consist of five members,  not four and not  surprisingly,  we think that
Asset Value should  control the  majority.  You made it clear that if anyone was
going to "take over", it was going to be you.  However,  even this  disagreement
need not  impede a fusion  slate if you,  like we,  are  willing  to submit  the
question of control to a vote of stockholders.

     We propose that Cortech submit to stockholders one proxy  statement,  which
would present each of the governance issues. Both



<PAGE>



Mr. Edward S. Finkelstein
June 16, 1998
Page 2

the Finkelsteins and Asset Value would agree to support the  declassification of
the Board and to set the number of vacancies at five. Management would present a
fusion  slate  consisting  of two  Finkelstein  nominees  and  two  Asset  Value
nominees.  Each side would also propose a third  nominee for the fifth  vacancy.
Each side would be permitted to enter a dissent to any  proposal,  including the
election of each side's third nominee.

     Entering a dissent would permit the other side equal opportunity to support
a measure.  Each position  statement  would have a word limit.  Although no side
would be able to  censor  the words of the other  side,  we would  have a common
understanding not to make personal  attacks.  Each side would be responsible for
negotiating text with the Securities and Exchange  Commission.  One ballot would
be  submitted,  giving  each  stockholder  the  ability to vote on every  issue,
including the election of directors. Asset Value and the Finkelstein Group would
split the cost of the proxy  material.  An  independent  inspector  of elections
would be jointly appointed to receive and count proxies.

     We told you that your stated ownership of  approximately  600,000 shares of
Cortech  stock  compared to the 2,770,000  Cortech  shares owned by Asset Value,
makes Asset Value the logical leader of Cortech's future.  You responded that we
ought not take your previously  stated  ownership at face value and we won't. As
we wrote to Bert Fingerhut,  whatever our  differences,  we all apparently agree
that Cortech can ill afford a costly  proxy  contest and it should be avoided if
possible.  To this end we have made this  proposal and if it is agreeable to you
and to the incumbent  Cortech Board, we should set about  discussing the details
immediately.  Unlike any other stockholder, Asset Value has expended substantial
sums of its money in  pursuit  of  stockholder  interests.  Therefore,  we would
request a response as soon as possible.

                                                Sincerely yours,



                                                Paul O. Koether
                                                President

cc:      Bert Fingerhut
         Mort Finkelstein
         Mark Lampert
         Dr. Charles Cohen
         Dr. Donald Kennedy
         Dr. Allen Misher




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission